Results for six models that showed nominally significant or borderline effects are summarized in Table 3 .
← all excerpts
Continuous glucose monitoring metrics based clustering in people living with type 1 diabetes identifies phenotypes associated with higher inflammation, metabolic dysfunction-associated steatotic liver disease risk, and lower insulin sensitivity.
1
—
—